Injection to guide radiation after flap surgery for head and neck cancer
Part of Cancer clinical trials.
This trial tests a special dye injection that helps doctors plan radiation therapy more precisely after you have surgery to remove a head or neck tumor and rebuild the area with a flap. The goal is to protect the rebuilt tissue from radiation damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a type of head or neck cancer called squamous cell carcinoma that is locally advanced (has grown into nearby tissues or lymph nodes)
- Your cancer is in the mouth or skin of the head or neck and you are scheduled for surgery that removes part of the area and rebuilds it with a flap
- You have not had surgery or radiation for this type of cancer before
- You are not allergic to the dye used in this test (Lipiodal or iodine-based contrast)
- You do not have severe asthma, severe kidney problems, overactive thyroid, or are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether patients with early-stage oral cancer who have surgery and lymph-node removal can skip radiation to the neck if certain favorable conditions are met. The goal is to reduce side effects like difficulty swallowing while keeping cancer control strong.
This trial tests a new way to give radiation therapy for head and neck cancer. By using a special PET scan to guide where higher radiation doses are given, doctors hope to improve treatment while reducing side effects. It is for people whose cancer is not early-stage and who will receive standard radiation therapy.
This trial studies whether a new surgical reconstruction method can improve outcomes for people with oral cavity or oropharyngeal squamous cell carcinoma (a type of head and neck cancer). The goal is to rebuild the area using a tissue flap while reducing problems where the tissue is taken from.
This trial tests a home-based light therapy device to see if it is practical and helpful for managing swelling (lymphoedema) and scarring (radiation fibrosis) in the head and neck after cancer treatment. You use the device at home, and it may reduce discomfort and improve your quality of life.
This trial tests a new way of giving radiation therapy, called adaptive radiation boost, for people with head and neck cancer. The goal is to see if this approach can better target the cancer and possibly improve outcomes.
This trial tests whether giving radiation therapy in a specific way (compartmentalized) after surgery for head and neck cancer is safe and effective. It is for people with certain types of head and neck cancer that have been removed, and aims to improve outcomes while managing side effects.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.